Variable | Participants (n = 54) |
---|---|
Age, years | 24.4 ± 15.3 |
Female sex, n (%) | 33 (61.1) |
Body mass index (adults), kg/m2a | 27.2 ± 6.7 |
Body mass index z-scoreb (children ’c) | 0.87 ± 0.89 |
Glycosylated hemoglobin, mmol/mol (%) | 61.5±9.7 (7.7±0.7) |
Duration of type 1 diabetes, years | 12.1±9.4 |
Duration of pump use, years | 7.3 ± 4.7 |
Total daily dosage of insulin, units | 47.1 ± 25.8 |
Continuous glucose monitoring use prior to study, n (%) | 35(64.8%) |
Intermittently scanned | 18 (33.3) |
Real-time CGM | 17 (31.5) |
Diabetes-related complications, n (%) | 5 (9.3) |
Severe hypoglycemia admissions | 0 (0) |
Microalbuminuria, n (%) | 3 (5.6) |
Retinopathy, n (%) | 2 (3.7) |
New Zealand Deprivation Index 2018d | 4.4 ± 2.7 |